Wen‐Ming Chen

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

Jesús F. San Miguel, Vânia Hungria, Sung‐Soo Yoon et al. · The Lancet Oncology · 2014 · 781 citations

Hematological Malignancy, Double-blind Phase 3, Medicine +9

Scenedesmus obliquus CNW-N as a potential candidate for CO2 mitigation and biodiesel production

Shih‐Hsin Ho, Wen‐Ming Chen, Jo‐Shu Chang · Bioresource Technology · 2010 · 343 citations

Potential Candidate, Carbon Sequestration, Engineering +6

Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2

Ming-De Huang, Wen‐Ming Chen, Fuzhen Qi et al. · Molecular Cancer · 2015 · 244 citations · Full text

Dark H2 fermentation from sucrose and xylose using H2-producing indigenous bacteria: Feasibility and kinetic studies

Yung-Chung Lo, Wen‐Ming Chen, Chun‐Hsiung Hung et al. · Water Research · 2007 · 228 citations

H2-producing Indigenous Bacteria, Engineering, Food Fermentation +9

8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential

Yuning Song, Hao Xu, Wen‐Ming Chen et al. · MedChemComm · 2014 · 223 citations

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +14